(S)-3-(1H-INDOL-3-YL)-N-(4-(4-METHOXYPHENYL)THIAZOL-2-YL)-2-(4-METHYLPHENYLSULFONAMIDO)PROPANAMIDE, 95%, 100mg

4-n-Butylaniline, 95.0%, 25g

Methyl 3-Aminopyrazine-2-carboxylate>98.0%(GC)(T)1g

4-Indanol, 95.0%, 250mg

1,1-Cyclopropanedicarboxylic acid, 97.0%, 1g

Hyaluronate Dodecasaccharide>95.0%(HPLC)1mg

5-(2-Fluorophenyl)isoxazole, 97%, 1g

Acide éthylènediamine tétraacétique, min 99%, 2,5 kg, emballage plastique.

3-Bromo-2-fluorobenzotrifluoride, 97.0%, 500g

tert-Butyl 2-bromo-7-azaspiro[3.5]nonane-7-carboxylate, 95.0%, 5g

4-Cyanoquinuclidine, 99.0%, 10g

[S(R)]-N-[(R)-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]phenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 250mg

2-Chloro-5-(2,4-dichlorobenzoyl)pyridine, 97.0%, 1g